Advertisement

99mTc-polyphosphonate labelling – Enhancement of a novel method for the quantification of osteogenic differentiation of MSCs in vitro

Published:December 30, 2020DOI:https://doi.org/10.1016/j.injury.2020.12.017

      Highlights

      • This study assesses the usability of a variety of tracers for a recently developed, highly sensitive, quantitative and non-destructive method for evaluating the in vitro amount of mineral produced by osteogenic differentiated mesenchymal stem cells in a monolayer cell culture using the radioactive tracer 99mTechnetium.
      • The presented results suggest that the novel method works superbly with all three commercially available 99mTechnetium tracers (MDP, DPD, HDP) and therefore this method can be used worldwide.
      • Furthermore, the timepoint when the labelling is performed is of little importance, which makes the planning and scheduling of osteogenic stem cell experiments more flexible.

      Abstract

      Bone tissue engineering is a fast-growing field in regenerative medicine. Consequently, there is a high demand for new, fast and reliable methods to track and quantify the osteogenic differentiation of cells. Recently, a novel method was published to non-destructively quantify the hydroxyapatite content of monolayer and 3-dimensional mesenchymal stem cell cultures using the ability of 99mTechnetium-methylene diphosphonate (MDP), a well-established tracer in clinical nuclear medicine, to bind to newly synthesized hydroxyapatite. In the present study, two other commonly used 99mTechnetium tracers, 2,3-dicarboxypropane-1,1-diphosphonate (DPD) and hydroxydiphosphonate (HDP), were evaluated to see if they could also be used for the same purpose. Furthermore, we investigated if labelling at various timepoints influenced the effectiveness of the labelling. The results were analysed using one-factor ANOVA followed by Bonferroni post-hoc testing. This revealed a highly significant difference between the three osteogenic groups at each timepoint compared to their corresponding negative controls. However, there was no statistically significant difference between the three different tracers (MDP, DPD, HDP) in the osteogenic groups. Therefore all three tracers are of similar value when quantifying the extracellular hydroxylapatite content in osteogenic stem cells cultures.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Injury
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Bruder S.P.
        • Jaiswal N.
        • Haynesworth S.E.
        Growth kinetics, self-renewal, and the osteogenic potential of purified human mesenchymal stem cells during extensive subcultivation and following cryopreservation.
        J Cell Biochem. 1997; 64: 278-294
        • Heino T.J.
        • Hentunen T.A.
        Differentiation of osteoblasts and osteocytes from mesenchymal stem cells.
        Curr Stem Cell Res Ther. 2008; 3: 131-145
        • Jaiswal N.
        • et al.
        Osteogenic differentiation of purified, culture-expanded human mesenchymal stem cells in vitro.
        J Cell Biochem. 1997; 64: 295-312
        • Jaiswal R.K.
        • et al.
        Adult human mesenchymal stem cell differentiation to the osteogenic or adipogenic lineage is regulated by mitogen-activated protein kinase.
        J Biol Chem. 2000; 275: 9645-9652
        • Bruder S.P.
        • Fox B.S.
        Tissue engineering of bone. Cell based strategies.
        Clin Orthop Relat Res. 1999; : S68-S83
        • Marion N.W.
        • Mao J.J.
        Mesenchymal stem cells and tissue engineering.
        Methods Enzymol. 2006; 420: 339-361
        • Dominici M.
        • et al.
        Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement.
        Cytotherapy. 2006; 8: 315-317
        • Horwitz E.M.
        • et al.
        Clarification of the nomenclature for MSC: the International Society for Cellular Therapy position statement.
        Cytotherapy. 2005; 7: 393-395
        • Irving J.T.
        Theories of mineralization of bone.
        Clin Orthop Relat Res. 1973; : 225-236
        • Lievremont M.
        • Potus J.
        • Guillou B.
        Use of alizarin red S for histochemical staining of Ca2+ in the mouse; some parameters of the chemical reaction in vitro.
        Acta Anat (Basel). 1982; 114: 268-280
        • Gilmore S.K.
        • Whitson S.W.
        • Bowers Jr., D.E.
        A simple method using alizarin red S for the detection of calcium in epoxy resin embedded tissue.
        Stain Technol. 1986; 61: 89-92
        • Gregory C.A.
        • et al.
        An Alizarin red-based assay of mineralization by adherent cells in culture: comparison with cetylpyridinium chloride extraction.
        Anal Biochem. 2004; 329: 77-84
        • Vilmann H.
        The in vivo staining of bone with alizarin red S.
        J Anat. 1969; 105: 533-545
        • Langenbach F.
        • Handschel J.
        Effects of dexamethasone, ascorbic acid and beta-glycerophosphate on the osteogenic differentiation of stem cells in vitro.
        Stem Cell Res Ther. 2013; 4: 117
        • von Kossa J.
        Über die im Organismus künstlich erzeugbaren Verkalkungen.
        Beitr Path Anat Allg Path. 1901; 29: 163
        • Grossner T.
        • et al.
        (99m)Tc-methyl-diphosphonate binding to mineral deposits in cultures of marrow-derived mesenchymal stem cells in osteogenic medium.
        Tissue Eng Part C Methods. 2019; 25: 49-57
        • Wong K.K.
        • Piert M.
        Dynamic bone imaging with 99mTc-labeled diphosphonates and 18F-NaF: mechanisms and applications.
        J Nucl Med. 2013; 54: 590-599
        • Grossner T.L.
        • Haberkorn U.
        • Gotterbarm T.
        (99m)Tc-Hydroxydiphosphonate quantification of extracellular matrix mineralization in 3D human mesenchymal stem cell cultures.
        Bone Joint Res. 2019; 8: 333-341
        • Davis M.A.
        • Jones A.L.
        Comparison of 99mTc-labeled phosphate and phosphonate agents for skeletal imaging.
        Semin Nucl Med. 1976; 6: 19-31
        • Buell U.
        • et al.
        Comparison of tc-99m MDP, HMDP, and DPD with respect to bone-to-soft tissue ratios.
        J Nucl Med. 1983; 24: 1201-1202
        • Bergqvist L.
        • et al.
        Clinical comparison of bone scintigraphy with 99Tcm-DPD, 99Tcm-HDP and 99Tcm-MDP.
        Acta Radiol Diagn (Stockh). 1984; 25: 217-223
        • Fruhling J.
        • Verbist A.
        • Balikdjian D.
        Which diphosphonate for routine bone scintigraphy (MDP, HDP or DPD)?.
        Nucl Med Commun. 1986; 7: 415-425
        • Lantto T.
        • et al.
        99Tcm-MDP and 99Tcm-DPD in pathologic bone lesions. a visual and quantitative comparison.
        Acta Radiol. 1987; 28: 631-633
        • Giannoudis P.V.
        • Einhorn T.A.
        • Marsh D.
        Fracture healing: the diamond concept.
        Injury. 2007; 38: S3-S6
        • Behnia H.
        • et al.
        Repair of alveolar cleft defect with mesenchymal stem cells and platelet derived growth factors: a preliminary report.
        J Craniomaxillofac Surg. 2012; 40: 2-7
        • Faundez A.A.
        • Taylor S.
        • Kaelin A.J.
        Instrumented fusion of thoracolumbar fracture with type I mineralized collagen matrix combined with autogenous bone marrow as a bone graft substitute: a four-case report.
        Eur Spine J. 2006; 15: 630-635
        • Torres J.
        • et al.
        Bone marrow stem cells added to a hydroxyapatite scaffold result in better outcomes after surgical treatment of intertrochanteric hip fractures.
        Biomed Res Int. 2014; 2014451781
        • Kang S.H.
        • et al.
        Bone regeneration potential of allogeneic or autogeneic mesenchymal stem cells loaded onto cancellous bone granules in a rabbit radial defect model.
        Cell Tissue Res. 2014; 355: 81-88
        • Kadiyala S.
        • et al.
        Culture expanded canine mesenchymal stem cells possess osteochondrogenic potential in vivo and in vitro.
        Cell Transplant. 1997; 6: 125-134
        • Jager M.
        • et al.
        Proliferation and osteogenic differentiation of mesenchymal stem cells cultured onto three different polymers in vitro.
        Ann Biomed Eng. 2005; 33: 1319-1332
        • Zheng C.
        • et al.
        Stem cell-based bone and dental regeneration: a view of microenvironmental modulation.
        Int J Oral Sci. 2019; 11: 23
        • Dunn A.
        • et al.
        Biomaterial and stem cell-based strategies for skeletal muscle regeneration.
        J Orthop Res. 2019; 37: 1246-1262
        • Dimarino A.M.
        • Caplan A.I.
        • Bonfield T.L.
        Mesenchymal stem cells in tissue repair.
        Front Immunol. 2013; 4: 201
        • Khan W.S.
        • et al.
        An osteoconductive, osteoinductive, and osteogenic tissue-engineered product for trauma and orthopaedic surgery: how far are we?.
        Stem Cells Int. 2012; 2012236231
        • Haleem A.M.
        • et al.
        The clinical use of human culture-expanded autologous bone marrow mesenchymal stem cells transplanted on platelet-rich fibrin glue in the treatment of articular cartilage defects: a pilot study and preliminary results.
        Cartilage,. 2010; 1: 253-261
        • Undale A.H.
        • et al.
        Mesenchymal stem cells for bone repair and metabolic bone diseases.
        Mayo Clin Proc. 2009; 84: 893-902
        • Hoemann C.D.
        • El-Gabalawy H.
        • McKee M.D.
        In vitro osteogenesis assays: influence of the primary cell source on alkaline phosphatase activity and mineralization.
        Pathol Biol (Paris),. 2009; 57: 318-323
        • Arinzeh T.L.
        Mesenchymal stem cells for bone repair: preclinical studies and potential orthopedic applications.
        Foot Ankle Clin. 2005; 10 (viii): 651-665
        • Oryan A.
        • et al.
        Role of mesenchymal stem cells in bone regenerative medicine: what is the evidence?.
        Cells Tissues Organs. 2017; 204: 59-83
        • Stanford C.M.
        • et al.
        Primary human bone cultures from older patients do not respond at continuum levels of in vivo strain magnitudes.
        J Biomech. 2000; 33: 63-71
        • Boyde A.
        • et al.
        Scanning electron microscopy of bone cells in culture.
        Cell Tissue Res. 1976; 166: 65-70
        • Maniatopoulos C.
        • Sodek J.
        • Melcher A.H.
        Bone formation in vitro by stromal cells obtained from bone marrow of young adult rats.
        Cell Tissue Res. 1988; 254: 317-330
        • Squire M.W.
        • Ricci J.L.
        • Bizios R.
        Analysis of osteoblast mineral deposits on orthopaedic/dental implant metals.
        Biomaterials. 1996; 17: 725-733
        • Basdra E.K.
        • Komposch G.
        Transmission and scanning electron microscopic analysis of mineralized loci formed by human periodontal ligament cells in vitro.
        J Orofac Orthop. 1999; 60: 77-86
        • Layman D.L.
        • Ardoin R.C.
        An in vitro system for studying osteointegration of dental implants utilizing cells grown on dense hydroxyapatite disks.
        J Biomed Mater Res. 1998; 40: 282-290
        • Yamamoto M.
        • Kato K.
        • Ikada Y.
        Ultrastructure of the interface between cultured osteoblasts and surface-modified polymer substrates.
        J Biomed Mater Res. 1997; 37: 29-36
        • Macri-Pellizzeri L.
        • et al.
        Live quantitative monitoring of mineral deposition in stem cells using tetracycline hydrochloride.
        Tissue Eng Part C Methods. 2018; 24: 171-178
        • Grossner T.
        • Haberkorn U.
        • Gotterbarm T.
        (18)F-based quantification of the osteogenic potential of hMSCs.
        Int J Mol Sci. 2020; 21
        • Mele M.
        • et al.
        Computer analysis of Tc-99m DPD and Tc-99m MDP kinetics in humans: concise communication.
        J Nucl Med. 1983; 24: 334-338